Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer. Gil-Sierra MD, Del Pilar Briceno-Casado M, Sanchez-Hidalgo M. JAMA Oncol 2022 Feb 10. pii: 2789075. doi: 10.1001/jamaoncol.2021.7787.

Read + Share

Amedeo Smart

Independent Medical Education

Gil-Sierra MD, Del Pilar Briceno-Casado M, Sanchez-Hidalgo M. Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer. JAMA Oncol 2022 Feb 10. pii: 2789075. doi: 10.1001/jamaoncol.2021.7787.
PMID: 35142795